SPOTLIGHT -
Three new studies on genetic risk factors and lifestyle; the transition from cognitive health to Alzheimer disease; and metabolic syndrome in depressed older adults.
Positive Phase 2 Data for NBI-1065845 in Adults With Major Depressive Disorder
Blue Light Blockers: A Behavior Therapy for Mania
The Week in Review: April 15-19
Blue Light, Depression, and Bipolar Disorder
Treatment-Resistant Geriatric Depression: Augmenting or Switching an Antidepressant
New Phase 3 Study Results on Lumateperone, An Adjunctive Therapy to Antidepressants